Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4

BACKGROUND AND AIMS: The hallmark of non-alcoholic fatty liver disease (NAFLD) is the excessive hepatic lipid accumulation. Currently, no pharmacotherapy exists for NAFLD. However, the glucagon-like peptide-1 receptor agonists have recently emerged as potential therapeutics. Here, we sought to ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Errafii, Khaoula, Al-Akl, Neyla S., Khalifa, Olfa, Arredouani, Abdelilah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173795/
https://www.ncbi.nlm.nih.gov/pubmed/34078383
http://dx.doi.org/10.1186/s12967-021-02885-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173795/
https://www.ncbi.nlm.nih.gov/pubmed/34078383
http://dx.doi.org/10.1186/s12967-021-02885-4

Ejemplares similares